Neprilysin protects against cerebral amyloid angiopathy and aβ-induced degeneration of cerebrovascular smooth muscle cells

Brain Pathology

Volumn 21, Issue 5, 2011, Pages 594-605

  Miners, James Scott ^a   Kehoe, Patrick ^a   Love, Seth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

amyloid toxicity; CAA; cerebral amyloid angiopathy; neprilysin

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; COMPLEMENTARY DNA; MEMBRANE METALLOENDOPEPTIDASE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD VESSEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL NECROSIS; SCORING SYSTEM; VASCULAR AMYLOIDOSIS; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; BLOOD VESSELS; CELLS, CULTURED; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MYOCYTES, SMOOTH MUSCLE; NEPRILYSIN; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 80052022534     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00486.x     Document Type: Article

References (62)

1. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM, (1998) Progression of cerebral amyloid angiopathy: accumulation of amyloid-β40 in affected vessels. J Neuropathol Exp Neurol 57: 353-359. (Pubitemid 28182634)
2. Angelisova P, Drbal K, Horejsi V, Cerny J, (1999) Association of CD10/neutral endopeptidase 24.11 with membrane microdomains rich in glycosylphosphatidylinositol-anchored proteins and Lyn kinase. Blood 93: 1437-1439. (Pubitemid 29076165)
3. Attems J, Jellinger KA, Lintner F, (2005) Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 110: 222-231. (Pubitemid 41430650)
4. Braak H, Braak E, (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
5. Burgermeister P, Calhoun ME, Winkler DT, Jucker M, (2000) Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models. Ann N Y Acad Sci 903: 307-316. (Pubitemid 30251571)
6. Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JA, Perry VH, Weller RO, (2008) Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol 34: 131-144. (Pubitemid 351327967)
7. Carpentier M, Robitaille Y, DesGroseillers L, Boileau G, Marcinkiewicz M, (2002) Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61: 849-856.
8. Chalmers K, Wilcock GK, Love S, (2003) APOE Îμ 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein. Neuropathol Appl Neurobiol 29: 231-238. (Pubitemid 36718171)
9. Davis J, Van Nostrand WE, (1996) Enhanced pathologic properties of Dutch-type mutant amyloid β-protein. Proc Natl Acad Sci USA 93: 2996-3000. (Pubitemid 26114352)
10. Eckman EA, Adams SK, Troendle FJ, Stodola BA, Kahn MA, Fauq AH, et al, (2006) Regulation of steady-state β-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. J Biol Chem 281: 30471-30478. (Pubitemid 44582103)
11. El-Amouri SS, Zhu H, Yu J, Gage FH, Verma IM, Kindy MS, (2007) Neprilysin protects neurons against Aβ peptide toxicity. Brain Res 1152: 191-200. (Pubitemid 46802503)
12. Ervin JF, Pannell C, Szymanski M, Welsh-Bohmer K, Schmechel DE, Hulette CM, (2004) Vascular smooth muscle actin is reduced in Alzheimer disease brain: a quantitative analysis. J Neuropathol Exp Neurol 63: 735-741. (Pubitemid 38891089)
13. Farris W, Schutz SG, Cirrito JR, Shankar GM, Sun X, George A, et al, (2007) Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am J Pathol 171: 241-251. (Pubitemid 47339241)
14. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A, (1995) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 45: 461-466.
15. Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH, et al, (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J Biol Chem 270: 7013-7016.
16. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT, (1995) Apolipoprotein E Îμ4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38: 254-259.
17. Hardy J, (2006) Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis 9: 151-153. (Pubitemid 44253307)
18. Hemming ML, Patterson M, Reske-Nielsen C, Lin L, Isacson O, Selkoe DJ, (2007) Reducing amyloid plaque burden via ex vivo gene delivery of an Aβ-degrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med 4: e262.
19. Hulette CM, Ervin JF, Edmonds Y, Antoine S, Stewart N, Szymanski MH, et al, (2009) Cerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease. J Neuropathol Exp Neurol 68: 417-424.
20. Hyman BT, (1998) New neuropathological criteria for Alzheimer disease. Arch Neurol 55: 1174-1176. (Pubitemid 28427486)
21. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, et al, (2001) Metabolic regulation of brain Aβ by neprilysin. Science 292: 1550-1552.
22. Iwata N, Mizukami H, Shirotani K, Takaki Y, Muramatsu S, Lu B, et al, (2004) Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain. J Neurosci 24: 991-998. (Pubitemid 38146610)
23. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y, (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13: 45-53.
24. Jarrett JT, Berger EP, Lansbury PT Jr, (1993) The C-terminus of the β protein is critical in amyloidogenesis. Ann N Y Acad Sci 695: 144-148.
25. Kanemitsu H, Tomiyama T, Mori H, (2003) Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci Lett 350: 113-116. (Pubitemid 37101425)
26. Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, et al, (1993) Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 623: 142-146. (Pubitemid 23267401)
27. Keage HA, Carare RO, Friedland RP, Ince PG, Love S, Nicoll JA, et al, (2009) Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol 9: 3.
28. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, et al, (2003) Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40: 1087-1093. (Pubitemid 38032786)
29. Love S, Nicoll JA, Hughes A, Wilcock GK, (2003) APOE and cerebral amyloid angiopathy in the elderly. Neuroreport 14: 1535-1536. (Pubitemid 37083144)
30. Love S, Miners S, Palmer J, Chalmers K, Kehoe P, (2009) Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. Front Biosci 14: 4778-4792.
31. Marr RA, Rockenstein E, Mukherjee A, Kindy MS, Hersh LB, Gage FH, et al, (2003) Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci 23: 1992-1996. (Pubitemid 36368884)
32. Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG, (2006) Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol 65: 1012-1021. (Pubitemid 44521802)
33. Miners JS, Verbeek MM, Rikkert MO, Kehoe PG, Love S, (2008) Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid. J Neurosci Methods 167: 229-236. (Pubitemid 350245527)
34. Miners JS, Baig S, Tayler H, Kehoe PG, Love S, (2009) Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. J Neuropathol Exp Neurol 68: 902-914.
35. Miners JS, van Helmond Z, Kehoe PG, Love S, (2010) Changes with age in the activities of β-secretase and the Aβ-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme. Brain Pathol 20: 794-802.
36. Nicoll JA, Burnett C, Love S, Graham DI, Ironside JW, Vinters HV, (1996) High frequency of apolipoprotein E Îμ2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 39: 682-683. (Pubitemid 26143609)
37. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ, (1996) The apolipoprotein E Îμ4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47: 190-196. (Pubitemid 26243882)
38. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN, (1996) Apolipoprotein E-Îμ4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 148: 2083-2095.
39. Revesz T, Holton JL, Lashley T, Plant G, Rostagno A, Ghiso J, Frangione B, (2002) Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 12: 343-357. (Pubitemid 34743217)
40. Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL, (2003) Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 62: 885-898. (Pubitemid 37159029)
41. Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, Huang SM, et al, (2005) Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation. Nat Med 11: 434-439. (Pubitemid 40562335)
42. Soontornniyomkij V, Choi C, Pomakian J, Vinters HV, (2010) High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease. Hum Pathol 41: 1601-1608.
43. Stopa EG, Butala P, Salloway S, Johanson CE, Gonzalez L, Tavares R, et al, (2008) Cerebral cortical arteriolar angiopathy, vascular β-amyloid, smooth muscle actin, Braak stage, and APOE genotype. Stroke 39: 814-821. (Pubitemid 351619548)
44. Sutton ET, Hellermann GR, Thomas T, (1997) β-amyloid-induced endothelial necrosis and inhibition of nitric oxide production. Exp Cell Res 230: 368-376. (Pubitemid 27190657)
45. Thal DR, Papassotiropoulos A, Saido TC, Griffin WS, Mrak RE, Kolsch H, et al, (2010) Capillary cerebral amyloid angiopathy identifies a distinct APOE Îμ4-associated subtype of sporadic Alzheimer's disease. Acta Neuropathol 120: 169-183.
46. Tian J, Shi J, Smallman R, Iwatsubo T, Mann DM, (2006) Relationships in Alzheimer's disease between the extent of Aβ deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol Appl Neurobiol 32: 332-340.
47. Trembath D, Ervin JF, Broom L, Szymanski M, Welsh-Bohmer K, Pieper C, Hulette CM, (2007) The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype. Acta Neuropathol 113: 23-31. (Pubitemid 44782926)
48. Tsuji T, Mimori Y, Nakamura S, Kameyama M, (1987) A micromethod for the isolation of large and small microvessels from frozen autopsied human brain. J Neurochem 49: 1796-1800. (Pubitemid 17164637)
49. Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C, et al, (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 157: 1283-1298.
50. van Helmond Z, Heesom K, Love S, (2009) Characterisation of two antibodies to oligomeric Aβ and their use in ELISAs on human brain tissue homogenates. J Neurosci Methods 176: 206-212.
51. van Helmond Z, Miners JS, Kehoe PG, Love S, (2010) Higher soluble amyloid β concentration in frontal cortex of young adults than in normal elderly or Alzheimer's disease. Brain Pathol 20: 787-793.
52. van Helmond Z, Miners JS, Kehoe PG, Love S, (2010) Oligomeric Aβ in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy. Brain Pathol 20: 468-480.
53. Van Nostrand WE, Davis-Salinas J, Saporito-Irwin SM, (1996) Amyloid β-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders. Ann N Y Acad Sci 777: 297-302. (Pubitemid 26149205)
54. Vance JE, Hayashi H, Karten B, (2005) Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol 16: 193-212. (Pubitemid 40432121)
55. Vinters HV, Gilbert JJ, (1983) Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14: 924-928. (Pubitemid 14205243)
56. Vinters HV, Secor DL, Read SL, Frazee JG, Tomiyasu U, Stanley TM, et al, (1994) Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. Ultrastruct Pathol 18: 333-348. (Pubitemid 24184171)
57. Wang Z, Natte R, Berliner JA, van Duinen SG, Vinters HV, (2000) Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid β proteins to human cerebral microvessel and aortic smooth muscle cells. Stroke 31: 534-538. (Pubitemid 30078193)
58. Weller RO, Nicoll JA, (2005) Cerebral amyloid angiopathy: both viper and maggot in the brain. Ann Neurol 58: 348-350. (Pubitemid 41266620)
59. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO, (2008) Perivascular drainage of amyloid-β peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol 18: 253-266. (Pubitemid 351430402)
60. Wenham PR, Price WH, Blandell G, (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337: 1158-1159.
61. Wisniewski HM, Wegiel J, (1994) β-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol 87: 233-241.
62. Zipfel GJ, Han H, Ford AL, Lee JM, (2009) Cerebral amyloid angiopathy: progressive disruption of the neurovascular unit. Stroke 40: S16-S19.